6:30 PM SIGN-IN & DINNER • 7:00 PM - 8:30 PM
BANDOL 1 (NEW WYNN SPACE)
CE: Comprehensive Cystic Fibrosis Management: A Review for Specialty Pharmacists
As a genetic life-limiting disease, cystic fibrosis (CF) affects more than 30,000 children and adults in the United States and more than double those individuals worldwide. In the 1950s, the poor survival rate of children diagnosed with CF made it difficult for them to live long enough to enter elementary school, but advancements in therapies have dramatically increased the average lifespan to approximately 37 years. Management of these patients’ disease is complex and includes a combination of therapies with a primary goal of maintaining lung function to as close to normal as possible and providing supplemental therapies. Pharmacists should understand the current care paradigm and the role of CF transmembrane conductance regulator (CFTR) modulators in individuals with specific CF mutations. Specialty pharmacists play an intrinsic role as part of the multidisciplinary team that is able to help monitor and tailor these therapies to provide a personalized approach through patient-specific counseling.
Emily Middleton Stephan